Received Nov 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | P5F7T | — |
Cut finger; Adjuvant component of SHINGRIX broke / shattered when another nurse removed the flip-off cap.; Pharmaceutical product complaint; This non-serious case was reported by a nurse via call center representative and described the occurrence of laceration of finger in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number P5F7T, expiry date 25-APR-2027) for prophylaxis. This case was associated with a product complaint. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced laceration of finger (Verbatim: Cut finger), product vial breakage (Verbatim: Adjuvant component of SHINGRIX broke / shattered when another nurse removed the flip-off cap.) and pharmaceutical product complaint (Verbatim: Pharmaceutical product complaint). The outcome of the laceration of finger was not reported, and the outcome of the product vial breakage and pharmaceutical product complaint were not applicable. It was unknown if the reporter considered the laceration of finger to be related to Shingrix. It was unknown if the company considered the laceration of finger to be related to Shingrix. Additional Information: GSK Receipt Date: 17-OCT-2025 The nurse reported that one vial of the adjuvant component of Shingrix broke / shattered when another nurse removed the flip-off cap. Because the vial broke while the nurse was holding the vial, the nurse's finger was cut.